Diazoxide
- Product NDC
- 13517-100
- 11-digit product format
- 135170100
- Labeler code
- 13517
- Product ID
- 13517-100_11c83c92-145b-486a-90f3-d759c358d091
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- diazoxide
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- e5 Pharma, LLC
- Application
- ANDA211050
- Marketing category
- ANDA
- Marketing start
- 2019-12-11
- Substance
- DIAZOXIDE
- Active strength
- 50 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Diazoxide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DIAZOXIDE | 50 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O5CB12L4FN |
| Rxcui | 197593 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13517-100-30 | Diazoxide | 30 mL in 1 BOTTLE, DROPPER | SUSPENSION | 30 | | 12 |
| 13517-100-30 | Diazoxide | 1 in 1 CARTON | SUSPENSION | 1 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13517-100 | DIAZOXIDE SUSPENSION [E5 PHARMA, LLC] | 11 | Current NDC, Legacy NDC, 2 package rows | 20250213_c0237320-2d3f-4907-a4d3-08f138aa4ca8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13517-100-30 | 13517010030 | 1 BOTTLE, DROPPER in 1 CARTON (13517-100-30) / 30 mL in 1 BOTTLE, DROPPER | 2019-12-11 | 0000-00-00 | No | No | Current |